APPLETON, WI - March 17, 2026 - PRESSADVANTAGE - McCormick Industries, a precision machining company serving diverse ...
Oberon Investments Group has launched a new global thematic equity fund, positioning it as a differentiated alternative to ...
Topline data from Phase 3 OnPrime/GOG-3076 ovarian cancer registrational trial of Olvi-Vec expected in 2H26 ---- Interim systemic lung cancer ...
The biotech industry needs to stop waiting for a rebound. The pandemic changed everything, though not in the ways most people ...
Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) (“Acurx” or the “Company”), a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for difficult‑to‑treat bacterial ...
In Gaza, we watch people being starved by Israel. In rich countries, we watch people starving themselves. The situations are ...
Kodiak Sciences Inc. (Nasdaq: KOD), today reported recent business highlights and financial results for the fourth ...
ICOTYDE is the first and only IL-23R targeted oral peptide that delivers complete skin clearance and a favorable safety profile in a once-daily pill Approval supported by four phase 3 studies that met ...
Post hoc analyses of BIMZELX (bimekizumab-bkzx) using the first consensus definition of psoriasis on-treatment remission:Published by the National ...
Novel immunotherapeutics have transformed oncology, moving away from broad, non-specific treatments toward highly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results